American Century Companies
STRO icon

American Century Companies’s Sutro Biopharma STRO Stock Holding History

American Century Companies’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-9,303
Closed -$171K – 2955
2024
Q4 		$171K Buy
9,303
+2,095
+29% +$64K ﹤0.01% 2803
2024
Q3 		$249K Buy
7,208
+527
+8% +$20.7K ﹤0.01% 2706
2024
Q2 		$196K Sell
6,681
-681
-9% -$26.9K ﹤0.01% 2728
2024
Q1 		$416K Buy
7,362
+3,015
+69% +$133K ﹤0.01% 2515
2023
Q4 		$187K Buy
4,347
+625
+17% +$19.8K ﹤0.01% 2714
2023
Q3 		$129K Buy
3,722
+871
+31% +$37.9K ﹤0.01% 2683
2023
Q2 		$133K Buy
2,851
+1,385
+94% +$68.9K ﹤0.01% 2625
2023
Q1 		$65.7K Buy
1,466
+184
+14% +$11.7K ﹤0.01% 2596
2022
Q4 		$104K Buy
+1,282
New +$89.1K ﹤0.01% 2451

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

American Century Companies's STRO Position: Q1 2025 in Review

American Century Companies sold out of Sutro Biopharma (STRO) in Q1 2025, closing a stake of 9,303 shares — an estimated $171K sold.

American Century Companies first reported a position in STRO in Q4 2022 and held it in 9 quarters. The position peaked at $416K in Q1 2024. 112 funds tracked by Wall St. Rank hold STRO as of Q1 2025.

  • American Century Companies reported no remaining Sutro Biopharma position as of Q1 2025 after selling out during the quarter.
  • American Century Companies sold 9,303 Sutro Biopharma shares in Q1 2025, an estimated $171K.
  • American Century Companies first reported a position in Sutro Biopharma in Q4 2022 and held it in 9 quarters.
  • American Century Companies's Sutro Biopharma position peaked at $416K in Q1 2024.
  • 112 funds tracked by Wall St. Rank held Sutro Biopharma as of Q1 2025.

Based on American Century Companies's 13F filing for Q1 2025, filed 13 May 2025.